This work investigates whether age is among the predisposing factors for breast cancer. Breast cancer is heterogeneous malignant cells whose specific age profiles exponentially increases until menopause after which it rises gently slowly thereby reflecting the superimposition of the early and late onset rates of breast cancer. The early onset breast cancers represent mainly the untimely life transforming or inherited consequences on the undeveloped epithelium, while late-onset breast cancers in most cases are likely to follow an extended exposure to supporting stimulus of vulnerable epithelium, which has botched to age normally. Biomarker studies and clinical observations indicates that the latter staged breast cancer types often develop slowly and are less biologically aggressive compared to the early staged breast cancers despite being under the control of hormone receptors such as growth factor receptor abbreviated as (HER2) and estrogen receptor (ER), expressions hence supporting the conclusion that breast cancer biology is age dependent.
Approximately twelve percent of women across the globe in the current society are annually affected by breast cancer. Moreover, while breast cancer incidence increases with age advancement, patients of younger age at diagnosis are largely associated with increase in the mortality rate. This research discusses most of the age-related factors, which affect the identification or diagnosis, treatment, and management of breast cancer incidence; examining main concepts and exploring vital areas, which calls for additional research. Ageing as a predisposing factor for breast cancer will be examined in connection to diagnosis and treatment with special reference to nodal status, hormone factors, breast cancer subtypes and genetic status. Further, although narrowly, the study will also touch on the future expectations of breast cancer identification and treatment through examination of some rising potential technologies and breast cancer tests like the miRNA.
Table of Contents
1. Introduction
2. Literature Review Related to the Topic
2.1 i. Lifetime Risks and Incidence of Breast Cancer by Age and Molecular Subtype
2.2 ii. Genetics and Breast Cancer Risks with Age
2.3 iii. Prognosis
2.4 iv. The length of menstrual cycle and the Age at menarche
2.5 v. Age at Menopause
2.6 vi. microRNAs and breast cancer
3. Methodology
3.1 Case 1: A Meta-analysis and Systematic Review of the Risk Factors for Breast Cancer for Women of between 40 and 60 Years
3.2 Case 2: A Vivid Analysis of the Progesterone Receptor Negative, Estrogen Receptor Negative, and HER2 Negative Invasive Breast Cancers or rather the Triple Negative Phenotypes
4. Results
5. Discussion
6. Limitations
7. Conclusion
8. Recommendations
Research Objectives and Topics
This research aims to explore and analyze whether aging acts as a primary predisposing factor for breast cancer among women in the United Kingdom, specifically examining how age-related variations influence diagnosis, treatment options, and patient outcomes.
- The correlation between increasing age and breast cancer incidence.
- Genetic mutations (such as BRCA1/BRCA2) and their age-dependent impact.
- The influence of hormonal factors, including menarche and menopause, on cancer risk.
- Molecular profiling and breast cancer subtypes across different age groups.
- Clinical management challenges for younger versus elderly patient populations.
Excerpt from the Book
Introduction
Breast cancer is mainly the commonly diagnosed cancer disease among most women in the United Kingdom with the exclusion of squamous and basal cell carcinomas of the skin. It is foremost the leading cause of death for the majority of women globally, which accounts for about 22.5 percent of cancer incidences and 13 percent of all mortalities that are related to cancer. The lifetime risks of acquiring breast cancer, currently stand at 1 out of 8 women; however, more than 40 percent of the affected patients are 65 years and more, thus accounting for about 60 percent of the total deaths resulting from breast cancer incidences. It is interesting to note that the predisposing factor for developing breast cancer before 49 years is one out of fifty-three, which rises at 50-59 years to one out of forty-three and much higher between 60 and 69 years to one out of twenty-three (Torre et al., p, 103, 2015). Moreover, the risk of developing the disease increases significantly to 1/15 for women at 70 years and above.
Summary of Chapters
Introduction: Provides an overview of the global prevalence of breast cancer, highlighting the significant correlation between age and increasing mortality and incidence rates.
Literature Review Related to the Topic: Examines existing research on biological, genetic, and hormonal risk factors, including the impact of menarche, menopause, and molecular subtypes on breast cancer.
Methodology: Details the systematic review and meta-analysis approach used to evaluate risk factors, specifically focusing on women aged 40–60 and triple-negative breast cancer phenotypes.
Results: Presents findings from the data analysis, confirming that breast cancer incidence rises significantly with age and that specific biological factors vary by age bracket.
Discussion: Interprets the research findings, emphasizing the heterogeneity of breast cancer in elderly populations and the influence of modifiable factors like body mass index.
Limitations: Acknowledges the constraints of the study, including the reliance on English-language literature and the challenges of excluding certain cofounding variables.
Conclusion: Synthesizes the evidence that age is a fundamental predisposing factor and calls for improved awareness, screening, and counseling.
Recommendations: Suggests practical lifestyle changes and further research into advanced mammography techniques to improve early detection.
Keywords
Breast Cancer, Aging, Oncology, Risk Factors, Mammography, Hormone Therapy, BRCA1, BRCA2, Menopause, Menarche, Triple-Negative Phenotype, Molecular Profiling, Public Health, Mortality Rate, Cancer Screening.
Frequently Asked Questions
What is the primary focus of this research?
The work investigates the role of aging as a predisposing factor for breast cancer, analyzing how it influences the development, diagnosis, and management of the disease in women.
What are the central thematic areas covered?
The paper covers the relationship between age and incidence, the impact of genetic mutations, hormonal influences throughout a woman's life, and the clinical challenges of managing breast cancer in both younger and elderly patients.
What is the main objective of the study?
The primary objective is to explore and analyze whether aging contributes significantly to breast cancer risk in the United Kingdom, focusing on how age variations affect treatment decisions.
Which scientific methodology is employed?
The research uses a biological-based literature review and systematic analysis of existing studies, databases, and clinical registries to synthesize data on age-related breast cancer risks.
What topics are discussed in the main body?
The main body discusses molecular subtypes, genetic predisposition (BRCA genes), hormonal milestones like menarche and menopause, and clinical outcomes for different age cohorts.
Which keywords characterize this work?
Key terms include breast cancer, aging, molecular profiling, BRCA1/2 mutations, mammography screening, and hormone-related risk factors.
How does menopause impact the risk of breast cancer?
The study notes that menopause represents a period of changing hormonal production, and the timing of menopause significantly alters the risk profile, with later menopause often associated with higher risks.
Why is triple-negative breast cancer discussed separately?
Triple-negative breast cancer is analyzed as a specific, more aggressive phenotype that shows distinct prevalence patterns across different age groups, particularly in younger women.
- Quote paper
- Gabby Ian (Author), 2018, Breast Cancer Research. Ageing as Predisposing Factor, Munich, GRIN Verlag, https://www.grin.com/document/1045118
